Form 4/A for PGNY Progyny, Inc.
Accepted 2026-09-18 18:46:29 ET · period of report 2026-09-10 · accession 0001551306-26-000154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2026-09-18 18:46 | 2026-09-10 | PGNY | GORDON KEVIN K | Dir | M - OptEx | $13.00 | +22.0K | 28.8K | +324% | +$286.0K |
| DA | 2026-09-18 18:46 | 2026-09-10 | PGNY | GORDON KEVIN K | Dir | F - Tax | $27.24 | -10.5K | 18.3K | -36% | -$286.0K |
| DA | 2026-09-18 18:46 | 2026-09-10 | PGNY | GORDON KEVIN K | Dir | S - Sale+OE | $27.12 | -11.5K | 6,792 | -63% | -$311.9K |
| DA | 2026-09-18 18:46 | 2026-09-10 | PGNY | GORDON KEVIN K | Dir | M - OptEx | $0.00 | -22.0K | 22.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-10 | M | A | 22,000 | $13.00 | 28,792 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-10 | F | D | 10,500 | $27.24 | 18,292 | D | — | — | |
| 3 | Common | Common Stock | 2026-09-10 | S | D | 11,500 | $27.12 | 6,792 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.99 to $27.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (F2) This Form 4 is being filed to correct a clerical error in a previously filed Form 4. The weighted average for the transaction was inadvertently reported as $27.9442 instead of $27.1181. All other information previously reported remains unchanged. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-09-10 | M | D | 22,000 | $0.00 | 22,000 | D | $13.00 · — to 2029-10-11 | 22,000 Common Stock | (F3) The shares are fully vested. |